BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8243 related articles for article (PubMed ID: 2241108)

  • 1. Phenotypic stability of B16-BL6 melanoma exposed to low levels of tyrosine and phenylalanine.
    Elstad CA; Meadows GG
    Anticancer Res; 1990; 10(5A):1313-8. PubMed ID: 2241108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of B16-BL6 murine melanoma metastatic phenotype by tyrosine and phenylalanine restriction in the absence of host selection pressures.
    Elstad CA; Meadows GG
    Anticancer Res; 1993; 13(2):523-8. PubMed ID: 8517667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine and phenylalanine restriction sensitizes adriamycin-resistant P388 leukemia cells to adriamycin.
    Elstad CA; Thrall BD; Raha G; Meadows GG
    Nutr Cancer; 1996; 25(1):47-60. PubMed ID: 8837861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phorbol 12-myristate 13-acetate enhances nm23 gene expression in murine melanocytes but not in syngeneic B16-BL6 melanoma variants.
    Huijzer JC; McFarland M; Niles RM; Meadows GG
    J Cell Physiol; 1996 Mar; 166(3):487-94. PubMed ID: 8600152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attachment, invasion, chemotaxis, and proteinase expression of B16-BL6 melanoma cells exhibiting a low metastatic phenotype after exposure to dietary restriction of tyrosine and phenylalanine.
    Uhlenkott CE; Huijzer JC; Cardeiro DJ; Elstad CA; Meadows GG
    Clin Exp Metastasis; 1996 Mar; 14(2):125-37. PubMed ID: 8605726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for nutrient modulation of tumor phenotype: impact of tyrosine and phenylalanine restriction.
    Elstad CA; Meadows GG; Aslakson CJ; Starkey JR
    Adv Exp Med Biol; 1994; 354():171-83. PubMed ID: 7520663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary restriction of tyrosine and phenylalanine: inhibition of metastasis of three rodent tumors.
    Abdallah RM; Starkey JR; Meadows GG
    J Natl Cancer Inst; 1987 Apr; 78(4):759-69. PubMed ID: 3470551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of the suppression of metastatic phenotype by tyrosine and phenylalanine restriction.
    Elstad CA; Meadows GG; Abdallah RM
    Clin Exp Metastasis; 1990; 8(5):393-416. PubMed ID: 2202533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine and phenylalanine restriction induces G0/G1 cell cycle arrest in murine melanoma in vitro and in vivo.
    Fu YM; Yu ZX; Ferrans VJ; Meadows GG
    Nutr Cancer; 1997; 29(2):104-13. PubMed ID: 9427972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic transfer of metastatic activity by uptake of highly metastatic B16 melanoma cell-released exosomes.
    Hao S; Ye Z; Li F; Meng Q; Qureshi M; Yang J; Xiang J
    Exp Oncol; 2006 Jun; 28(2):126-31. PubMed ID: 16837903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of phenotypic diversity in the B16 mouse melanoma relative to spontaneous metastasis.
    Stackpole CW
    Cancer Res; 1983 Jul; 43(7):3057-65. PubMed ID: 6850615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of lactose derivatives on metastatic potential of B16 melanoma cells.
    Oguchi H; Toyokuni T; Dean B; Ito H; Otsuji E; Jones VL; Sadozai KK; Hakomori S
    Cancer Commun; 1990; 2(9):311-6. PubMed ID: 2206779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells.
    Murata J; Ayukawa K; Ogasawara M; Fujii H; Saiki I
    Invasion Metastasis; 1997; 17(2):82-93. PubMed ID: 9561027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of sialidase activity and G(M3) content in B16 melanoma variants with different metastatic potential.
    Sawada M; Moriya S; Shineha R; Satomi S; Miyagi T
    Acta Biochim Pol; 1998; 45(2):343-9. PubMed ID: 9821865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrosphelide B suppressed metastasis through inhibition of adhesion of sLe(x)/E-selectin molecules.
    Fukami A; Iijima K; Hayashi M; Komiyama K; Omura S
    Biochem Biophys Res Commun; 2002 Mar; 291(4):1065-70. PubMed ID: 11866473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of tyrosine and phenylalanine limitation of cytotoxicity of chimeric TGF-alpha toxins on B16BL6 murine melanoma in vitro.
    Fu YM; Li YQ; Meadows GG
    Nutr Cancer; 1998; 31(1):1-7. PubMed ID: 9682242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium ascorbate enhancement of carbidopa-levodopa methyl ester antitumor activity against pigmented B16 melanoma.
    Pierson HF; Meadows GG
    Cancer Res; 1983 May; 43(5):2047-51. PubMed ID: 6831435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of metastatic tumor growth in mouse lung by repeated administration of polyethylene glycol-conjugated catalase: quantitative analysis with firefly luciferase-expressing melanoma cells.
    Hyoudou K; Nishikawa M; Umeyama Y; Kobayashi Y; Yamashita F; Hashida M
    Clin Cancer Res; 2004 Nov; 10(22):7685-91. PubMed ID: 15570002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of peroxidation in murine melanoma by dietary tyrosine-phenylalanine restriction, levodopa methylester chemotherapy, and sodium ascorbate supplementation.
    Pierson HF; Meadows GG
    J Natl Cancer Inst; 1985 Sep; 75(3):507-16. PubMed ID: 3861901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of B16-BL6 melanoma lung colonies by semisynthetic sulfaminoheparosan sulfates from E. coli K5 polysaccharide.
    Poggi A; Rossi C; Casella N; Bruno C; Sturiale L; Dossi C; Naggi A
    Semin Thromb Hemost; 2002 Aug; 28(4):383-92. PubMed ID: 12244486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 413.